Bank Of America Corp Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $3.88 Million - $4.27 Million	-4,300 Reduced 6.78%	59,100 $56.9 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $10.1 Million - $11.5 Million	13,000 Added 25.79%	63,400 $55.7 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $39.8 Million - $47.2 Million	-56,800 Reduced 52.99%	50,400 $36.2 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $72.5 Million - $88.2 Million	106,600 Added 17766.67%	107,200 $88.1 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $10.6 Million - $11.5 Million	-15,000 Reduced 96.15%	600 $432,000

Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $8.67 Million - $10.9 Million	15,100 Added 3020.0%	15,600 $10.7 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $1.25 Million - $1.47 Million	-2,100 Reduced 80.77%	500 $349,000
Q4 2021 Feb 08, 2022	BUY	$543.48 - $670.97 $597,828 - $738,067	1,100 Added 73.33%	2,600 $1.64 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $58.7 Million - $69.7 Million	-102,300 Reduced 98.55%	1,500 $908,000
Q2 2021 Sep 13, 2021	BUY	$472.8 - $558.54 $49.1 Million - $58 Million	103,800 New	103,800 $58 Million

1,437

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $114B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.